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o Cardiotropic Viruses
espect National Borders?
e read the interesting article of Andréoletti et al. (1) showing
ctive coxsackieviral B (CV-B) infection in post-mortem endo-
yocardial tissue of patients who died suddenly due to acute
yocardial infarction. The demonstration of sarcolemmal dystro-
hin disruption in the same tissue areas that were infected by
V-B is of potential groundbreaking value for the understanding
f viral pathogen-induced myocardial damage in humans. Both
V-B genomes and CV-B capsid proteins were detected in the
eart tissues of patients with myocardial infarction by reverse
ranscriptase-polymerase chain reaction and immunohistochemis-
ry, thereby suggesting active virus replication.
However, it is interesting to find that about one-half of the
yocytes (exemplary pictured in Fig. 1 of this article [1]) reveal
irus replication in patients with coronary artery disease as dem-
nstrated by the presence of the enteroviral VP1 capsid protein (1).
revious extensive investigations regarding immunohistochemical
tainings for the detection of enteroviral proteins in cardiac tissue
y applying the antibody from clone 5-D8/1 (Dako, Glostrup,
enmark), which was also applied in this study, revealed a
onsiderable unspecific cross-reaction with uninfected necrotic or
poptotic human cardiomyocytes (2). In fact, using this antibody,
e found that false positive staining of cardiomyocytes can be
etected in all kinds of cardiac diseases where affected cardiomyo-
ytes are present including patients with myocardial infarction and
oronary artery disease. Therefore, the suitability of this antibody
or the visualization of CV-B capsid proteins is questionable at
east in diseased hearts.
In addition, it is surprising that Andréoletti et al. (1) found
nteroviruses to be the only cardiotropic viral agents active in
rance. In contrast, endomyocardial biopsies in Germany consis-
ently and almost exclusively contain parvovirus B19 (PVB19) and
uman herpes virus type 6 whereas CV-B is a rare finding (3–7).
s PVB19 may lead to endothelial dysfunction (8,9) and is found
n the majority of patients with a clinical picture of acute
yocardial infarction despite a normal coronary anatomy (10), one
ight expect to find also PVB19 genomes in French patients dying
f acute myocardial infarction. Of course, there are very little data
n endomyocardial biopsy findings in German patients with acute
yocardial infarction, and it cannot be excluded that one would
nd CV-B in such a cohort.
How can this astonishing difference between endomyocardial
iopsy findings in French and German people be explained? Is
iral disease of the heart a locally restricted phenomenon? Does
V-B show a tropism for wine-drinking humans while PVB19 is
ainly attracted to beer drinkers? Is there a mechanism preventing
iruses from crossing the French-German border? Or is the
ifference not a real one, but is due to methodological differences tpolymerase chain reaction primers?) in identifying small amounts
f viral genome. Whatever the reason for this discrepancy, it is
mportant to verify the findings of Andréoletti et al. (1) in other
abs with experience in identifying very small amounts of viral
enomes in human myocardium.
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eply
ur multicentric French case-control study demonstrates for the
rst time that enteroviruses (EVs) may significantly contribute to
he pathogenesis of acute myocardial infarction (MI) (1). These
